Retrieval of Real World Data for Clinical Research
1.0.0 - trial-use International flag

This page is part of the Retrieval of Real World Data for Clinical Research (v1.0.0: STU1) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Table of Contents

...0 Table of Contents
...1 Home
...2 Cohort Building
...3 Finding Data
...4 Technical Considerations
...5 Determining usage from Medication Resources
...6 Downloads
...7 Acknowledgements
...8 Related References
...9 Acute Coronary Syndrome Study
...10 Anti-TNFa Treatment Study
...11 Diabetes Study
...12 COVID-19 Vaccine Effectiveness Study
....13 Artifacts Summary
....13.1 EncounterDischargeDispositionSearchParameter
....13.2 ObservationInterpretationSearchParameter
....13.3 ProcedureOutcomeSearchParameter
....13.4 EncounterRwd
....13.5 MedicationAdministrationRwd
....13.6 MedicationDispenseRwd
....13.7 MedicationStatementRwd
....13.8 ObservationLaboratoryResultsRwd
....13.9 ProcedureRwd
....13.10 ACS Example Condition Codes
....13.11 ACS Example Oral Antiplatelet Drug Codes
....13.12 AntiTNFA Example Drug Codes
....13.13 Covid-19 Example Test Codes
....13.14 ACS Example Clopidogrel Codes
....13.15 AntiTNFA Example Condition Codes
....13.16 Diabetes Example Condition Codes
....13.17 Diabetes Example Dialysis Test Codes
....13.18 Diabetes Example Test Codes
....13.19 Covid-19 Example Vaccine Codes
....13.20 ACS Example Prasugrel Codes
....13.21 Covid-19 Example Condition Codes
....13.22 ACS Example Ticagrelor Codes
....13.23 CapabilityStatement-RWDServer
....13.24 RWDEncounter
....13.25 RWDLabResult
....13.26 RWDLaboratory
....13.27 RWDMedicationAdministration
....13.28 RWDMedicationDispense
....13.29 RWDMedicationRequest
....13.30 RWDMedicationStatementFromAdministration
....13.31 RWDMedicationStatementFromDispense
....13.32 RWDMedicationStatementFromRequest
....13.33 RWDPatient
....13.34 RWDProblem
....13.35 RWDProcedure